C07D 239/32
One oxygen, sulfur or nitrogen atom
C07D239/32 (One oxygen, sulfur or nitrogen atom) appears on 3,713 US grants and 3,184 published applications in this corpus.
Search patents in C07D- Granted patents
- 3,713
- Published applications
- 3,184
- Assignees
- 1,356
- Inventors
- 11,038
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 30 | 0 |
| 1977 | 29 | 0 |
| 1978 | 21 | 0 |
| 1979 | 22 | 0 |
| 1980 | 29 | 0 |
| 1981 | 36 | 0 |
| 1982 | 32 | 0 |
| 1983 | 33 | 0 |
| 1984 | 50 | 0 |
| 1985 | 45 | 0 |
| 1986 | 46 | 0 |
| 1987 | 54 | 0 |
| 1988 | 51 | 0 |
| 1989 | 68 | 0 |
| 1990 | 64 | 0 |
| 1991 | 71 | 0 |
| 1992 | 67 | 0 |
| 1993 | 77 | 0 |
| 1994 | 85 | 0 |
| 1995 | 86 | 0 |
| 1996 | 75 | 0 |
| 1997 | 88 | 0 |
| 1998 | 76 | 0 |
| 1999 | 75 | 0 |
| 2000 | 62 | 0 |
| 2001 | 65 | 8 |
| 2002 | 74 | 79 |
| 2003 | 69 | 122 |
| 2004 | 74 | 160 |
| 2005 | 62 | 167 |
| 2006 | 86 | 132 |
| 2007 | 84 | 136 |
| 2008 | 70 | 143 |
| 2009 | 104 | 173 |
| 2010 | 109 | 161 |
| 2011 | 99 | 127 |
| 2012 | 123 | 136 |
| 2013 | 138 | 157 |
| 2014 | 147 | 153 |
| 2015 | 149 | 179 |
| 2016 | 118 | 128 |
| 2017 | 148 | 164 |
| 2018 | 107 | 115 |
| 2019 | 89 | 97 |
| 2020 | 89 | 103 |
| 2021 | 62 | 102 |
| 2022 | 71 | 100 |
| 2023 | 56 | 113 |
| 2024 | 57 | 104 |
| 2025 | 51 | 68 |
| 2026 | 40 | 57 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Preparation method for pyrimidine-2-amine8 Sep 2026US 12,729,185 B2Institute for Basic Science
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Aptamer nucleic acid molecule, and complex and application thereof23 Jun 2026US 12,662,676 B2East China University of Science and Technology
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Neuroactive androgen receptor modulators and use thereof1 Oct 2026US 2026/0294908 A1ENDOCHEM PHARMACEUTICALS (BEIJING) CO., LTD. Beijing
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Hiv-1p rotease inhibitors and uses thereof17 Sep 2026US 2026/0272926 A1Purdue Research Foundation
Most cited
By later US patents
- Pyrimidine, cyanoguanidines as K-channel blockers1,019US 5,633,374 AThe Upjohn Company · 1997
- Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces208US 5,650,234 ASurface Engineering Technologies, Division of Innerdyne, Inc. · 1997
- Substituted 2-anilinopyrimidines useful as protein kinase inhibitors201US 5,958,935 ACelltech Therapeutics Limited · 1999
- Bi-aryl meta-pyrimidine inhibitors of kinases194US 7,528,143 B2TargeGen, Inc. · 2009
- Pyrimidine derivatives189US 5,260,440 AShionogi Seiyaku Kabushiki Kaisha · 1993